Article Information
History
- May 5, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Iris Finci1,*,
- Madelyn Yiseth Rojas Castro2,*,
- Iris Hasibra3,
- Jonilda Sulo4,5,
- Albana Fico3,
- Rovena Daja3,
- Adela Vasili3,
- Majlinda Kota3,
- Iria Preza6,
- Barbara Mühlemann7,8,
- Christian Drosten7,8,
- Richard Pebody1,
- Kathryn E. Lafond9,
- Esther Kissling2,
- Mark A. Katz1 and
- Silvia Bino3,4,†
- 1World Health Organization Regional Office for Europe, Copenhagen, Denmark
- 2Epiconcept, Paris, France
- 3Institute of Public Health, Tirana, Albania
- 4Southeast European Center for Surveillance and Control of Infectious Disease, Tirana, Albania
- 5Mediterranean and Black Sea Programme in Intervention Epidemiology Training (MediPIET), European Centre for Disease Prevention and Control (ECDC), Solna, Sweden
- 6World Health Organization, Country Office Albania, Tirana, Albania
- 7Institute of Virology, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt- Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany
- 8German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany
- 9Influenza Division, US Centers for Disease Control, Atlanta, Georgia
- ↵†Corresponding author: Silvia Bino, MD, PhD, silviabino{at}gmail.com
↵* These authors contributed equally
Posted May 05, 2023.
Primary series and booster COVID-19 vaccine effectiveness in a cohort of healthcare workers in Albania during a BA.1 and BA.2 variant period, January – May 2022
